Overview

Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis

Status:
Completed

Trial end date:
2007-02-01

Target enrollment:

Participant gender:

Summary

This study investigated the effectiveness and safety of oltipraz therapy in treating patients with cirrhosis induced by chronic hepatitis type B or C.

Phase:

Phase 2

Details

Lead Sponsor:

CJ HealthCare Corporation
HK inno.N Corporation

Treatments:

Oltipraz